Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation
The cannabinoid system has the ability to modulate cellular and molecular mechanisms, including excitotoxicity, oxidative stress, apoptosis, and inflammation, acting as a neuroprotective agent, by its relationship with signaling pathways associated to the control of cell proliferation, differentiation, and survival. Recent reports have raised new perspectives on the possible role of cannabinoid system in neurodegenerative diseases like Alzheimer disease’s (AD). AD is a neurodegenerative disorder characterized by the presence of amyloid plaques, neurofibrillary tangles, neuronal death, and progressive cognitive loss, which could be caused by energy metabolism impairment, changes in insulin signaling, chronic oxidative stress, neuroinflammation, Tau hyperphosphorylation, and Aβ deposition in the brain. Thus, we investigated the presumptive protective effect of the cannabinoid type 1 (CB1)-selective receptor agonist arachidonyl-2′-chloroethylamide (ACEA) against streptozotocin (STZ) exposure stimuli in an in vitro neuronal model (Neuro-2a neuroblastoma cells) and in vivo model (intracerebroventricular STZ injection), experimental models of sporadic AD. Our results demonstrated that ACEA treatment reversed cognitive impairment and increased activity of Akt and ERK triggered by STZ, and increased IR expression and increased the anti-apoptotic proteins levels, Bcl-2. In the in vitro model, ACEA was able to rescue cells from STZ-triggered death and modulated the NO release by STZ. Our study has demonstrated a participation of the cannabinoid system in cellular survival, involving the CB1 receptor, which occurs by positive regulation of the anti-apoptotic proteins, suggesting the participation of this system in neurodegenerative processes. Our data suggest that the cannabinoid system is an interesting therapeutic target for the treatment of neurodegenerative diseases.
KeywordsAgonist CB1 ACEA Neuroprotection Streptozotocin Alzheimer’s disease Neurodegeneration
Authors wish to thank the professor Dr. Julián Romero (Universidad Francisco de Vitoria, Madrid, Spain) for critical comments and his technical support during the process. We also thank to Dr. Maria Assunción de la Barreda Manso for her opinion and critical comments.
This work was supported by the Fundação de Amparo à Pesquisa do Estado de São Paulo-FAPESP (grant number 2014/06372-0). T.A.V. (1279985) and F.C. (1233360) are recipients of Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) fellowships.
F.C. designed the experiments, collected, and analyzed the data and wrote the paper; T.A.V. and A.P.C. collected, analyzed, and discussed the data; A.S.T. designed the experiments, discussed the data, wrote, edited, and commented on the manuscript. All authors approved the final version of the manuscript.
Compliance with Ethical Standards
The experimental protocol was evaluated and approved by the “Ethics Committee for Animal use” of the Institute of Biomedical Sciences, University of São Paulo (Protocol no. 33/55/02) following the Brazilian Federal Law (no. 11794; 10/08/2008). All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Conflict of Interest
The authors declare that they have no conflict of interest.
- Ahmad F, Nidadavolu P, Durgadoss L, Ravindranath V (2014) Critical cysteines in Akt1 regulate its activity and proteasomal degradation: implications for neurodegenerative diseases. Free Radic Biol Med 74:118–128. https://doi.org/10.1016/j.freeradbiomed.2014.06.004 CrossRefPubMedGoogle Scholar
- Blázquez C, Chiarlone A, Bellocchio L, Resel E, Pruunsild P, García-Rincón D, Sendtner M, Timmusk T, Lutz B, Galve-Roperh I, Guzmán M (2015) The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway. Cell Death Differ 22:1618–1629. https://doi.org/10.1038/cdd.2015.11 CrossRefPubMedPubMedCentralGoogle Scholar
- Café-Mendes CC, Ferro ES, Torrão AS, Crunfli F, Rioli V, Schmitt A, Falkai P, Britto LR, Turck CW, Martins-de-Souza D (2017) Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. J Proteome 151:97–105. https://doi.org/10.1016/j.jprot.2016.05.025 CrossRefGoogle Scholar
- Calderón FH, Bonnefont A, Muñoz FJ, Fernández V, Videla LA, Inestrosa NC (1999) PC12 and neuro 2ª cells have diferente susceptibilities to acetylcholinesterase-amyloid complexes, amyloid 25-35 fragment, glutamate, and hydrogen peroxide. J Neurosci Res 56:620–631. https://doi.org/10.1002/(SICI)1097-4547(19990615)56:6<620::AID-JNR8>3.0.CO;2-F CrossRefPubMedGoogle Scholar
- Coffer PJ, Geijsen N, M’rabet L, Schweizer RC, Maikoe T, Raaijmakers JAM, Lammers JWJ, Koenderman L (1998) Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J 329(Pt1):121–130CrossRefPubMedPubMedCentralGoogle Scholar
- Crunfli F, Mazucanti CH, De Moraes RCM, Costa AP, Rodrigues AC, Scavone C, Torrão AS (2018) NO-dependent Akt inactivation by S-nitrosylation as a possible mechanism of STZ-induced neuronal insulin resistance. J Alzheimers Dis 65:1427–1443. https://doi.org/10.3233/JAD-180284 CrossRefPubMedGoogle Scholar
- Di Marzo V, Verrijken A, Hakkarainen A, Petrosino S, Mertens I, Lundbom N, Piscitelli F, Westerbacka J, Soro-Paavonen A, Matias I, Van Gaal L, Taskinen MR (2009) Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. Eur J Endocrinol 161:715–722. https://doi.org/10.1530/EJE-09-0643 CrossRefPubMedGoogle Scholar
- El-Mir MY, Detaille D, R-Villanueva G, Esteban MD, Guigas B, Attia S, Fontaine E, Almeida A, Leverve X (2008) Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons. J Mol Neurosci 34:77–87. https://doi.org/10.1007/s12031-007-9002-1 CrossRefPubMedGoogle Scholar
- Esposito G, De Filippis D, Steardo L, Scuderi C, Savani C, Cuomoa V, Iuvone T (2006) CB1 receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci Lett 404:342–346. https://doi.org/10.1016/j.neulet.2006.06.012 CrossRefPubMedGoogle Scholar
- Esposito G, Ligresti A, Izzo AA, Bisogno T, Ruvo M, Di Rosa M, Di Marzo V, Iuvone T (2002) The endocannabinoid system protects rat glioma cells against HIV-1 tat protein-induced cytotoxicity: mechanism and regulation. J Biol Chem 277:50348–50354. https://doi.org/10.1074/jbc.M207170200 CrossRefPubMedGoogle Scholar
- Fernández-López D, Martínez-Orgado J, Nuñez E, Romero J, Lorenzo P, Moro MA, Lizasoain I (2006) Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res 60:169–173. https://doi.org/10.1203/01.pdr.0000228839.00122.6c CrossRefPubMedGoogle Scholar
- Ferrer I, Blanco R, Carmona M, Puig B (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons. J Neural Transm 108:1397–1415. https://doi.org/10.1007/s007020100016 CrossRefPubMedGoogle Scholar
- Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 105:423–438. https://doi.org/10.1007/s007020050068 CrossRefPubMedGoogle Scholar
- Jordan JD, He JC, Eungdamrong NJ, Gomes I, Ali W, Nguyen T, Bivona TG, Philips MR, Devi LA, Iyengar R (2005) Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through Gαo/i-triggered proteasomal degradation of Rap1GAPII. J Biol Chem 280:11413–11421. https://doi.org/10.1074/jbc.M411521200 CrossRefPubMedGoogle Scholar
- Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS (2016) Streptozotocin intracerebroventricular-induced neurotoxicity and brain insulin resistance: a therapeutic intervention for treatment of sporadic Alzheimer’s disease (sAD)-like pathology. Mol Neurobiol 53:4548–4562. https://doi.org/10.1007/s12035-015-9384-y CrossRefPubMedGoogle Scholar
- Kokona D, Thermos K (2015) Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: involvement of PI3K/Akt and MEK/ERK signaling pathways. Exp Eye Res 136:45–58. https://doi.org/10.1016/j.exer.2015.05.007 CrossRefPubMedGoogle Scholar
- Laezza C, Malfitano AM, Proto MC, Esposito I, Gazzerro P, Formisano P, Pisanti S, Santoro A, Caruso MG, Bifulco M (2010) Inhibition of 3-hydroxy-3-methylglutarylcoenzyme a reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. Endocr Relat Cancer 17:495–503. https://doi.org/10.1677/ERC-10-0009 CrossRefPubMedGoogle Scholar
- Martín-Moreno AM, Brera B, Spuch C, Carro E, García-García L, Delgado M, Pozo MA, Innamorato NG, Cuadrado A, de Ceballos ML (2012) Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J Neuroinflammation 9:8. https://doi.org/10.1186/1742-2094-9-8 CrossRefPubMedPubMedCentralGoogle Scholar
- Nicolas O, Gavin R, Braun N, Ureña JM, Fontana X, Soriano E, Aguzzi A, del Río JA (2007) Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion. FASEB J 21:3107–3117. https://doi.org/10.1096/fj.06-7827com CrossRefPubMedGoogle Scholar
- Numajiri N, Takasawa K, Nishiya T, Tanaka H, Ohno K, Hayakawa W, Asada M, Matsuda H, Azumi K, Kamata H, Nakamura T, Hara H, Minami M, Lipton SA, Uehara T (2011) On-off system for PI3-kinase-Akt signaling through S-nitrosylation of phosphatase with sequence homology to tensin (PTEN). Proc Natl Acad Sci U S A 108:10349–10354. https://doi.org/10.1073/pnas.1103503108 CrossRefPubMedPubMedCentralGoogle Scholar
- Osmanovic Barilar J, Knezovic A, Grünblatt E, Riederer P, Salkovic-Petrisic M (2015) Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease. J Neural Transm 122:565–576. https://doi.org/10.1007/s00702-014-1323-y CrossRefPubMedGoogle Scholar
- Paxinos G, Watson C (2007) The Rat Brain in Stereotaxic Coordinates. 6th Edition, Academic Press, San DiegoGoogle Scholar
- Ramalingam M, Kim S (2014) Insulin involved Akt / ERK and Bcl-2 / Bax pathways against oxidative damages in C6 glial cells. 9893:1–7. https://doi.org/10.3109/10799893.2014.970276
- Ramírez BG, Blázquez C, Gómez del Pulgar T, Guzmán M, de Ceballos ML (2005) Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25:1904–1913. https://doi.org/10.1523/JNEUROSCI.4540-04.2005 CrossRefPubMedGoogle Scholar
- Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie LA, Head E (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer’s disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28:3051–3059. https://doi.org/10.1523/JNEUROSCI.5620-07.2008 CrossRefPubMedGoogle Scholar
- Rutkowska M, Gliniak H (2009) The influence of ACEA: a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations. Pharmazie 64:598–601Google Scholar
- Ryu BR, Ko HW, Jou I, Noh JS, Gwag BJ (1999) Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J Neurobiol 39:536–546. https://doi.org/10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J CrossRefPubMedGoogle Scholar
- Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl:217–233. https://doi.org/10.1007/978-3-211-73574-9-28
- Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J Neural Transm 120:233–252. https://doi.org/10.1007/s00702-012-0877-9 CrossRefPubMedGoogle Scholar
- Salkovic-Petrisic M, Osmanovic J, Grünblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer’s disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-β. J Alzheimers Dis 18:729–750. https://doi.org/10.3233/JAD-2009-1184 CrossRefPubMedGoogle Scholar
- Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005–1015. https://doi.org/10.1111/j.1471-4159.2005.03637.x CrossRefPubMedGoogle Scholar
- Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M (2007) Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52:836–843. https://doi.org/10.1016/j.neuropharm.2006.10.005 CrossRefPubMedGoogle Scholar
- Song J, Hur BE, Bokara KK, Yang W, Cho HJ, Park KA, Lee WT, Lee KM, Lee JE (2014) Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med J 55:689–699. https://doi.org/10.3349/ymj.2014.55.3.689 CrossRefPubMedPubMedCentralGoogle Scholar
- Stygelbout V, Leroy K, Pouillon V, Ando K, D'Amico E, Jia Y, Luo HR, Duyckaerts C, Erneux C, Schurmans S, Brion JP (2014) Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology. Brain 137:537–552. https://doi.org/10.1093/brain/awt344 CrossRefPubMedGoogle Scholar
- Subramaniam S, Zirrgiebel U, Von Bohlen Und Halbach O, Strelau J, Laliberté C, Kaplan DR, Unsicker K (2004) ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3. J Cell Biol 165:357–369. https://doi.org/10.1083/jcb.200403028 CrossRefPubMedGoogle Scholar
- Van Der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, Micale V, Steardo L, Drago F, Iuvone T, Di Marzo V (2006) Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 63:1410–1424. https://doi.org/10.1007/s00018-006-6037-3 CrossRefPubMedGoogle Scholar
- Vrechi TA, Crunfli F, Costa AP, Torrão AS (2018) Cannabinoid receptor type 1 agonist ACEA protects neurons from death and attenuates endoplasmic reticulum stress-related apoptotic pathway signaling. Neurotox Res 33. https://doi.org/10.1007/s12640-017-9839-1
- Winters BD, Forwood SE, Cowell RA, Saksida LM, Bussey TJ (2004) Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe. J Neurosci 24:5901–5908. https://doi.org/10.1523/JNEUROSCI.1346-04.2004 CrossRefPubMedGoogle Scholar
- Zou S, Kumar U (2018) Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci 19. https://doi.org/10.3390/ijms19030833